when did glp 1 drugs become popular GLP-1s were first approved in 2005 for the treatment of type 2 diabetes. Over the past two decades, more versions of the medication have hit the market, becoming more accessible to patients On the Increase in Use

No reconstitution is required the product arrives ready for laboratory application via the nasal spray delivery format

Standard IV dosing for wellness applications ranges from 600 to 1,800 mg per session depending on the indication

However, the evidence is limited, and results from one proprietary formulation cannot automatically be applied to every spray, lozenge or liquid product

This improvement was hypothesized to be attributed to its purported anti-inflammatory action, including a potential decrease in myeloperoxidase (MPO) activity and histological inflammatory cell influx

With a tailored mix of magnesium, B-complex, vitamin C, and calcium, the Myers Cocktail is ideal for anyone seeking a boost in immunity, cognition, and whole-body recovery